GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Humedix Co Ltd (XKRX:200670) » Definitions » EV-to-FCF

Humedix Co (XKRX:200670) EV-to-FCF : 5.72 (As of Apr. 10, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Humedix Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Humedix Co's Enterprise Value is ₩240,552 Mil. Humedix Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩42,079 Mil. Therefore, Humedix Co's EV-to-FCF for today is 5.72.

The historical rank and industry rank for Humedix Co's EV-to-FCF or its related term are showing as below:

XKRX:200670' s EV-to-FCF Range Over the Past 10 Years
Min: -372.99   Med: 12.53   Max: 98.98
Current: 5.72

During the past 12 years, the highest EV-to-FCF of Humedix Co was 98.98. The lowest was -372.99. And the median was 12.53.

XKRX:200670's EV-to-FCF is ranked better than
87.23% of 548 companies
in the Drug Manufacturers industry
Industry Median: 23.42 vs XKRX:200670: 5.72

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-10), Humedix Co's stock price is ₩36100.00. Humedix Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩3795.000. Therefore, Humedix Co's PE Ratio (TTM) for today is 9.51.


Humedix Co EV-to-FCF Historical Data

The historical data trend for Humedix Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humedix Co EV-to-FCF Chart

Humedix Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.51 49.43 6.42 12.50 7.80

Humedix Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.50 6.50 7.51 7.17 7.80

Competitive Comparison of Humedix Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Humedix Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humedix Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Humedix Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Humedix Co's EV-to-FCF falls into.


;
;

Humedix Co EV-to-FCF Calculation

Humedix Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=240552.367/42078.73
=5.72

Humedix Co's current Enterprise Value is ₩240,552 Mil.
Humedix Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩42,079 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Humedix Co  (XKRX:200670) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Humedix Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=36100.00/3795.000
=9.51

Humedix Co's share price for today is ₩36100.00.
Humedix Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3795.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Humedix Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Humedix Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Humedix Co Business Description

Traded in Other Exchanges
N/A
Address
268 Anyang Dongan Game Metallurgy, 502 Gwanyang-dong Anyang Mega Valley, Anyang, Gyeonggi, KOR, 431-809
Humedix Co Ltd is a cosmeceutical healthcare company. It supplies Hyaluronic Acid raw material medicine of low molecule and the high molecule which are used in arthritis medicine, eyedrops and in injections for ophthalmology. Further, it is dedicated to the development of new functional materials with diverse physiological activities including vitamin derivatives and supplies a variety of functional materials. In addition, it offers various medical devices, cosmetic and health functional foods. The business activities are primarily carried out through South Korea.

Humedix Co Headlines

No Headlines